Patents by Inventor Stephane Beilles

Stephane Beilles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis
    Patent number: 9700540
    Abstract: The invention relates to dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis, formulations and associations comprising dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: July 11, 2017
    Assignee: SANOFI
    Inventors: Stephane Beilles, Sandra Chambonnet, Jean-Pierre Collaveri
  • Dronedarone for use in Leishmaniasis, Formulations and Associations for Use in Leishmaniasis
    Publication number: 20160151326
    Abstract: The invention relates to dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis, formulations and associations comprising dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis.
    Type: Application
    Filed: February 1, 2016
    Publication date: June 2, 2016
    Inventors: Stephane BEILLES, Sandra CHAMBONNET, Jean-Pierre COLLAVERI
  • PHARMACEUTICAL COMPOSITION AND DOSAGE FORM COMPRISING DRONEDARONE, AND PREPARATION METHOD THEREOF
    Publication number: 20150196528
    Abstract: The disclosure relates to a pharmaceutical composition for oral administration, containing, as active principle, a benzofuran derivative having antiarrhythmic activity, in particular dronedarone and the pharmaceutically acceptable salts thereof, and at least one lipid carrier, said pharmaceutical composition being intended to be used in unit dosage form of the capsule type, in particular with a hard shell. This pharmaceutical composition and the dosage form comprising such a composition aim to limit the meal time effect following oral administration in humans. The lipid carrier allows: the solubilization of the active principle of the invention; and the shielding thereof from the negative effects of pH in the intestinal tract, thereby allowing same to be spared from the meal effect to a significant extent.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Bernard ABRAMOVICI, Stephane BEILLES, Sandra CHAMBONNET, Jean-Claude GAUTIER
  • Dronedarone for use in Leishmaniasis, Formulations and Associations for Use in Leishmaniasis
    Publication number: 20150150841
    Abstract: The invention relates to dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis, formulations and associations comprising dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis.
    Type: Application
    Filed: May 22, 2013
    Publication date: June 4, 2015
    Inventors: Stephane Beilles, Sandra Chambonnet, Jean-Pierre Collaveri
  • Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
    Patent number: 9018250
    Abstract: The disclosure relates to a pharmaceutical composition for oral administration, containing, as active principle, a benzofuran derivative having antiarrhythmic activity, in particular dronedarone and the pharmaceutically acceptable salts thereof, and at least one lipid carrier, said pharmaceutical composition being intended to be used in unit dosage form of the capsule type, in particular with a hard shell. This pharmaceutical composition and the dosage form comprising such a composition aim to limit the meal time effect following oral administration in humans. The lipid carrier allows: the solubilization of the active principle of the invention; and the shielding thereof from the negative effects of pH in the intestinal tract, thereby allowing same to be spared from the meal effect to a significant extent.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: April 28, 2015
    Assignee: Sanofi
    Inventors: Bernard Abramovici, Stephane Beilles, Sandra Chambonnet, Jean-Claude Gautier
  • PHARMACEUTICAL COMPOSITION AND DOSAGE FORM COMPRISING DRONEDARONE, AND PREPARATION METHOD THEREOF
    Publication number: 20130245115
    Abstract: The disclosure relates to a pharmaceutical composition for oral administration, containing, as active principle, a benzofuran derivative having antiarrhythmic activity, in particular dronedarone and the pharmaceutically acceptable salts thereof, and at least one lipid carrier, said pharmaceutical composition being intended to be used in unit dosage form of the capsule type, in particular with a hard shell. This pharmaceutical composition and the dosage form comprising such a composition aim to limit the meal time effect following oral administration in humans. The lipid carrier allows: the solubilization of the active principle of the invention; and the shielding thereof from the negative effects of pH in the intestinal tract, thereby allowing same to be spared from the meal effect to a significant extent.
    Type: Application
    Filed: May 6, 2013
    Publication date: September 19, 2013
    Applicant: SANOFI
    Inventors: Bernard ABRAMOVICI, Stephane BEILLES, Sandra CHAMBONNET, Jean-Claude GAUTIER
  • ? crystalline form of perindopril tert-butylamine salt
    Patent number: 7259181
    Abstract: A ? crystalline form of the compound of formula (I): characterized by its powder X-ray diffraction data. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: August 21, 2007
    Assignee: Les Laboratoires Servier
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gérard Coquerel, Stéphane Beilles
  • Beta crystalline form of perindopril tert-butylamine salt
    Publication number: 20050203165
    Abstract: A ? crystalline form of the compound of formula (I): characterized by its powder X-ray diffraction data. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme.
    Type: Application
    Filed: February 4, 2005
    Publication date: September 15, 2005
    Applicant: LES LABORATORIES SERVIER
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gerard Coquerel, Stephane Beilles
  • New alpha crystalline form of perindopril tert-butylamine salt
    Publication number: 20050059609
    Abstract: An ? crystalline form of the compound of formula (I): characterized by its powder X-ray diffraction data. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme.
    Type: Application
    Filed: March 3, 2004
    Publication date: March 17, 2005
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gerard Coquerel, Stephane Beilles
  • Gamma crystalline form of perindopril tert-butylamine salt
    Publication number: 20040248817
    Abstract: A &ggr; crystalline form of the compound of formula (I): 1
    Type: Application
    Filed: March 29, 2004
    Publication date: December 9, 2004
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gerard Coquerel, Stephane Beilles
  • Novel $g(beta crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
    Publication number: 20040029813
    Abstract: &bgr; crystalline form of the compound of formula (I): 1
    Type: Application
    Filed: December 31, 2002
    Publication date: February 12, 2004
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gerard Coquerel, Stephane Beilles
  • Crystalline form of perindopril tert-butylamine salt
    Publication number: 20030186896
    Abstract: &agr; crystalline form of the compound of formula (I): 1
    Type: Application
    Filed: December 31, 2002
    Publication date: October 2, 2003
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gerard Coquerel, Stephane Beilles
  • Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same
    Publication number: 20030158121
    Abstract: &ggr; crystalline form of the compound of formula (I): 1
    Type: Application
    Filed: December 31, 2002
    Publication date: August 21, 2003
    Inventors: Bruno Pfeiffer, Yves-Michel Ginot, Gerard Coquerel, Stephane Beilles